-
Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment2020 Vaccine article Biochemistry, Genetics and Molecular Biology Virus-based gene therapy research Open access cited by 2 patents
Jerome H. H. V. Custers, Denny Kim, Maarten Leyssen, Marc Gurwith, Frank L. Tomaka, James S. Robertson, +10 more
84citations -
First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial
Pauline Verdijk, Johan L. van der Plas, Emilie M.J. van Brummelen, Rienk E. Jeeninga, Cornelis A. M. de Haan, Meta Roestenberg, +2 more
31citations -
Pyroptosis-inducing active caspase-1 as a genetic adjuvant in anti-cancer DNA vaccination2022 Vaccine article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 1 patent
Tsolère Arakelian, Koen Oosterhuis, Elena Tondini, Mandy Los, Jana Vree, Mariska van Geldorp, +7 more
29citations -
Characterization of Escherichia coli isolates potentially covered by ExPEC4V and ExPEC10V, that were collected from post-transrectal ultrasound-guided prostate needle biopsy invasive urinary tract and bloodstream infections2020 Vaccine article Biochemistry, Genetics and Molecular Biology Escherichia coli research studies cited by 14 patents
Elie Antoun Saade, Stefan Gravenstein, Curtis J. Donskey, Brigid M. Wilson, Bart Spiessens, Darren Abbanat, +3 more
17citations -
ESX-5-targeted export of ESAT-6 in BCG combines enhanced immunogenicity & efficacy against murine tuberculosis with low virulence and reduced persistence
Isis Heijmenberg, Aliabbas A. Husain, Harindra Darshana Sathkumara, Visai Muruganandah, Socorro Miranda‐Hernandez, Rajpal Singh Kashyap, +3 more
16citations
5 results